Park H, Lee S, Lee H
Inflamm Res. 2025; 74(1):19.
PMID: 39812811
DOI: 10.1007/s00011-025-01992-y.
Li L, Xu Q, Zhang X, Jiang Y, Zhang L, Guo J
Mater Today Bio. 2025; 30:101387.
PMID: 39742147
PMC: 11683329.
DOI: 10.1016/j.mtbio.2024.101387.
Harkness J, Nayak D, Sedlacek A, Cattley R, Hawse W, Watkins S
Cell Commun Signal. 2024; 22(1):598.
PMID: 39696592
PMC: 11657872.
DOI: 10.1186/s12964-024-01901-6.
Lee C, Choi H, Gurmessa S, Jang I, Kumar N, Jiang Z
Cancer Cell Int. 2024; 24(1):389.
PMID: 39580412
PMC: 11585098.
DOI: 10.1186/s12935-024-03569-x.
Brown R, Le H, Babcock I, Harris T, Gaultier A
Glia. 2024; 73(2):291-308.
PMID: 39495092
PMC: 11662982.
DOI: 10.1002/glia.24632.
Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy.
Huang Z, Huang S, Song S, Ding Y, Zhou H, Zhang S
Nat Commun. 2024; 15(1):8692.
PMID: 39375342
PMC: 11458765.
DOI: 10.1038/s41467-024-53084-w.
Elevated Salt or Angiotensin II Levels Induce CD38+ Innate Immune Cells in the Presence of Granulocyte-Macrophage Colony Stimulating Factor.
Smith H, Goodlett B, Navaneethabalakrishnan S, Mitchell B
Cells. 2024; 13(15.
PMID: 39120331
PMC: 11311366.
DOI: 10.3390/cells13151302.
Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity.
Xu Z, Xiao Z, Wang J, Qiu H, Cao F, Zhang S
Oncoimmunology. 2024; 13(1):2373526.
PMID: 38948931
PMC: 11212567.
DOI: 10.1080/2162402X.2024.2373526.
A pH/ROS dual-responsive system for effective chemoimmunotherapy against melanoma remodeling tumor immune microenvironment.
Wang L, He S, Liu R, Xue Y, Quan Y, Shi R
Acta Pharm Sin B. 2024; 14(5):2263-2280.
PMID: 38799639
PMC: 11119573.
DOI: 10.1016/j.apsb.2023.12.001.
Type I gamma phosphatidylinositol phosphate 5-kinase i5 controls cell sensitivity to interferon.
Ghosh C, Kakar R, Hoyle R, Liu Z, Guo C, Li J
Dev Cell. 2024; 59(8):1028-1042.e5.
PMID: 38452758
PMC: 11043016.
DOI: 10.1016/j.devcel.2024.02.005.
Deciphering metabolic crosstalk in context: lessons from inflammatory diseases.
Verheijen F, Tran T, Chang J, Broere F, Zaal E, Berkers C
Mol Oncol. 2024; 18(7):1759-1776.
PMID: 38275212
PMC: 11223610.
DOI: 10.1002/1878-0261.13588.
Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects.
Prado-Acosta M, Jeong S, Utrero-Rico A, Goncharov T, Webster J, Holler E
Sci Transl Med. 2023; 15(727):eadf8366.
PMID: 38117900
PMC: 11157567.
DOI: 10.1126/scitranslmed.adf8366.
Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects.
Chen J, Xu Y, Zhou M, Xu S, Varley A, Golubovic A
Proc Natl Acad Sci U S A. 2023; 120(50):e2309472120.
PMID: 38060560
PMC: 10723144.
DOI: 10.1073/pnas.2309472120.
Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines.
Bhatta R, Han J, Liu Y, Bo Y, Lee D, Zhou J
Nat Commun. 2023; 14(1):8047.
PMID: 38052869
PMC: 10697976.
DOI: 10.1038/s41467-023-43914-8.
Immunomodulatory effects of nanoparticles on dendritic cells in a model of allergic contact dermatitis: importance of PD-L2 expression.
Wong Lau A, Perez Pineda J, DeLouise L
Sci Rep. 2023; 13(1):15992.
PMID: 37749142
PMC: 10520013.
DOI: 10.1038/s41598-023-42797-5.
Immunomodulatory Effects of Nanoparticles on Dendritic Cells in a Model of Allergic Contact Dermatitis - Importance of PD-L2 Expression.
Wong Lau A, Perez Pineda J, DeLouise L
Res Sq. 2023; .
PMID: 37503107
PMC: 10371126.
DOI: 10.21203/rs.3.rs-3069059/v1.
